Offer - Urjas Oil for just ₹ 1 X
GRAFNOS 2MG CAPSULE is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of GRAFNOS 2MG CAPSULE safe for pregnant women?
Pregnant women may experience moderate side effects from Grafnos . It is best to stop taking Grafnos immediately and inform your doctor if you notice any discomfort.
Is the use of GRAFNOS 2MG CAPSULE safe during breastfeeding?
Grafnos can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of GRAFNOS 2MG CAPSULE on the Kidneys?
Grafnos can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of GRAFNOS 2MG CAPSULE on the Liver?
You may experience side effects on your liver after taking Grafnos . If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of GRAFNOS 2MG CAPSULE on the Heart?
Use of Grafnos may be dangerous for the heart. Do not use it without doctor's advice.
If you are suffering from any of the following diseases, you should not take GRAFNOS 2MG CAPSULE unless your doctor advises you to do so -
Is this GRAFNOS 2MG CAPSULE habit forming or addictive?
GRAFNOS 2MG CAPSULE does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking GRAFNOS 2MG CAPSULE as it does not make you drowsy.
Is it safe?
Yes, but take GRAFNOS 2MG CAPSULE only as per medical advice.
Is it able to treat mental disorders?
No, the use of GRAFNOS 2MG CAPSULE in mental disorders is not effective.
Interaction between Food and GRAFNOS 2MG CAPSULE
Information is not available on the interaction of any foods with GRAFNOS 2MG CAPSULE, due to a lack of research on this.
Interaction between Alcohol and GRAFNOS 2MG CAPSULE
Consuming GRAFNOS 2MG CAPSULE with alcohol can have many serious effects on your body.
No, you cannot take the Grafnos with Ibuprofen, as it may change the effect of the Grafnos and cause some serious side effects, always consult your doctor before taking this drug combination.
Take Grafnos as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Grafnos may cause swelling of the arms, hands, feet, ankles, or lower legs. It is one of the serious side effects of this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor immediately.
Yes, Grafnos is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as headache, diarrhea, constipation, nausea, vomiting. If you experience any discomfort after taking this do inform your doctor.
Grafnos injection is given by your doctor or nurse. Do not take it by own. Grafnos tablets or capsules are taken with or without food or as advised/prescribed by your doctor. The topical dosage form of Grafnos is applied 2 times a day and should be applied at the same time everyday, Do not apply more or less than the prescribed by the doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167